0001209191-21-026445.txt : 20210413
0001209191-21-026445.hdr.sgml : 20210413
20210413163714
ACCESSION NUMBER: 0001209191-21-026445
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210409
FILED AS OF DATE: 20210413
DATE AS OF CHANGE: 20210413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keresty Georgia
CENTRAL INDEX KEY: 0001773532
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37766
FILM NUMBER: 21823435
MAIL ADDRESS:
STREET 1: C/O ASPEN TECHNOLOGY, INC.
STREET 2: 20 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intellia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001652130
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 364785571
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-6200
MAIL ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-09
0
0001652130
Intellia Therapeutics, Inc.
NTLA
0001773532
Keresty Georgia
C/O INTELLIA THERAPEUTICS, INC.
40 ERIE STREET; SUITE 130
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2021-04-09
4
A
0
4955
0.00
A
4955
D
Stock Option (right to buy)
70.64
2021-04-09
4
A
0
7755
0.00
A
2031-04-08
Common Stock
7755
7755
D
Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
This option was granted on April 9, 2021 with respect to 7,755 shares of Common Stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan, with 33 1/3% vesting on April 9, 2022 and the remaining 66 2/3% vesting in 8 substantially equal quarterly installments thereafter.
/s/Jose E. Rivera, Attorney-In-Fact
2021-04-13